Concepedia

Jennifer Vaughn

JV

Statistics

Publications

4

Citations

332

H-Index

4

Active since

2015

Affiliations

Fred Hutch Cancer Center(Current)

Emory University

University of Washington

Jennifer Vaughn is an author at Fred Hutch Cancer Center specializing in immunology, immunotherapy, and medicine.

Top concepts

MedicineOncologyImmunologyImmunotherapyHealthPathologyHematologyCancer TherapyTumor ImmunityCancer Research

Publications per year

2015–2019

4

Publications

4

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Saad Z. Usmani, Fredrik Schjesvold, Albert Oriol et al. · The Lancet Haematology · 2019 · 237 citations · Full text

Hematological Malignancy, Medicine, Immunology +7

Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Jennifer Vaughn, Megan Othus, Morgan A. Powell et al. · JAMA Oncology · 2015 · 47 citations · Full text

Long‐term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

Jennifer Vaughn, Mohamed L. Sorror, Barry E. Storer et al. · Cancer · 2015 · 32 citations · Full text

Phase 1/2 trial of acalabrutinib plus pembrolizumab (Pem) in relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).

Thomas E. Witzig, Kami J. Maddocks, Sven de Vos et al. · Journal of Clinical Oncology · 2019 · 16 citations

R/r Dlbcl, Immunology, Immunoediting +20

1–4 of 4